agree with this. Current pricing would operate the company at a breakeven depending on the "bed penetration rate".
It's quite straightforward maths when you look at the number of beds Painchek need to be breakeven.
Probably a better metric for "break even" would be cashflow positive as cash determines whether a company raise capital or not..
That metric depends entirely on the operations spend and capex spend so there would be more variables to consider.
All in all I hope Painchek eventually get the FDA approval and open a larger market to sell their product.
That's the critical crux for the investment thesis if they can't acheive the penetration rates in existing markets (AU,UK).
- Forums
- ASX - By Stock
- PCK
- Painchek Simple Investment Thesis
PCK
painchek ltd
Add to My Watchlist
2.44%
!
4.2¢

Painchek Simple Investment Thesis, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.2¢ |
Change
0.001(2.44%) |
Mkt cap ! $77.36M |
Open | High | Low | Value | Volume |
4.1¢ | 4.2¢ | 4.1¢ | $5.303K | 129.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 225825 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.2¢ | 96270 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 225825 | 0.040 |
1 | 51351 | 0.039 |
1 | 131500 | 0.038 |
1 | 18349 | 0.037 |
3 | 330657 | 0.036 |
Price($) | Vol. | No. |
---|---|---|
0.042 | 96270 | 2 |
0.043 | 26000 | 1 |
0.044 | 228000 | 2 |
0.045 | 235710 | 2 |
0.047 | 95896 | 1 |
Last trade - 13.37pm 15/07/2025 (20 minute delay) ? |
Featured News
PCK (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online